Dergiler / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 6

A comparison of the effects of perindopril arginine and amlodipine on choroidal thickness in patients with primary hypertension

Sayfa
1247–1254
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Analysisof the changes occurring during the study revealed significant variation in MAP in Groups I and II, and in CT in Group I only.Conclusion: A gradual increase in CT developed with perindopril arginine therapy in patients with primary hypertension, while nosignificant change occurred in CT in the amlodipine group.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: This study aimed to investigate the effects of two different medical treatment options on choroidal thickness (CT) inpatients with primary hypertension.Materials and methods: Forty newly diagnosed primary hypertension patients and 21 healthy volunteers were included.
📊
Temel Bulgular & Veri:SubmacularCT using optical coherence tomography (OCT) was measured before treatment and at the third and sixth months after treatment.Results: Initial mean arterial pressure (MAP) values in Groups I and II and the control group were 113.4, 109.8, and 89.4 mmHg,respectively, and mean CT values were 257.9, 286.5, and 300.9 µm.
💡
Sonuç & Katkı:Analysisof the changes occurring during the study revealed significant variation in MAP in Groups I and II, and in CT in Group I only.Conclusion: A gradual increase in CT developed with perindopril arginine therapy in patients with primary hypertension, while nosignificant change occurred in CT in the amlodipine group.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: This study aimed to investigate the effects of two different medical treatment options on choroidal thickness (CT) inpatients with primary hypertension.Materials and methods: Forty newly diagnosed primary hypertension patients and 21 healthy volunteers were included. The patientswere randomly divided into two subgroups. Group I started on perindopril arginine and Group II started on amlodipine. SubmacularCT using optical coherence tomography (OCT) was measured before treatment and at the third and sixth months after treatment.Results: Initial mean arterial pressure (MAP) values in Groups I and II and the control group were 113.4, 109.8, and 89.4 mmHg,respectively, and mean CT values were 257.9, 286.5, and 300.9 µm. Mean MAP values in Groups I and II and the control group at thesixth month after treatment were 99.7, 99.6, and 90.2 mmHg, respectively, and mean CT values were 293.1, 286, and 297.4 µm. Analysisof the changes occurring during the study revealed significant variation in MAP in Groups I and II, and in CT in Group I only.Conclusion: A gradual increase in CT developed with perindopril arginine therapy in patients with primary hypertension, while nosignificant change occurred in CT in the amlodipine group.

🔖

Bu Makaleye Atıf Yap

İÇEL, E., İMAMOĞLU, H. İ., AKYOL, N., TÜRK, A., IÇEL, A. (2022). A comparison of the effects of perindopril arginine and amlodipine on choroidal thickness in patients with primary hypertension. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 6, 1247–1254. https://ajindex.com/articles/610155

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, Prabhakaran D. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens 2014; 32: 1170-1177.
  2. Gupta R, Pandey RM, Misra A, Agrawal A, Misra P, Dey S, Rao S, Menon VU, Kamalamma N, Vasantha Devi KP et al. High prevalence and low awareness, treatment and control of hypertension in Asian Indian women. J Hum Hypertens 2012; 26: 585-593.
  3. Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation 2000; 101: 329-335.
  4. Bhargava M, Ikram MK, Wong TY. How does hypertension affect your eyes? J Hum Hypertens 2012; 26: 71-83.
  5. James PA, Oparil S, Carter BL, Cushman WC, DennisonHimmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
  6. Kramkowski K, Mogielnicki A, Buczko W. The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol 2006; 57: 529-539.
  7. Brugts JJ, Ferrari R, Simoons ML. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease. Expert Rev Cardiovasc Ther 2009; 7: 345-360.
  8. Shetty K, Shetty R, Bairy L, Rao P, Kiran A, Shetty M, Deepak, Nayak V. A comparative study on clinical and biochemical parameters in amlodipine and cilnidipine treated hypertensive patients. J Clin Diagn Res 2017; 11: FC01-FC05. Mrejen S, Spaide RF. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 2013; 58: 387-429.
  9. Kur J, Newman EA, Chan-Ling T. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res 2012; 31: 377- 406. Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res 2010; 29: 144-168.
  10. Akyol N, Kalkisim A, Turk A, Kola M, Imamoglu HI. Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination. Cutan Ocul Toxicol 2017; 36: 397-403.
  11. Turk A, Ceylan OM, Arici C, Keskin S, Erdurman C, Durukan AH, Mutlu FM, Altinsoy HI. Evaluation of the nerve fiber layer and macula in the eyes of healthy children using spectraldomain optical coherence tomography. Am J Ophthalmol 2012; 153: 552-559.
  12. Kola M, Kalkisim A, Karkucak